# Aligos Therapeutics, Inc.: Form SC 13D/A, filed May 3, 2021

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: SC 13D/A
- Filed: 2021-05-03
- Accepted by EDGAR: May 3, 2021, 16:57 ET
- Period: not reported
- Accession: 0001193125-21-148141
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312521148141/d164832dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312521148141/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312521148141/d164832dsc13da.htm

Filed May 3, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-148141. Last ingested by Listed: Nov 14, 2026, 12:59 ET. No prices; not investment advice.
